Skip to main content

Numen

Numen is developing rapid at-home diagnostics and streamlined high-volume health data collection infrastructure aimed at driving cancer mortality toward zero. The platform combines bioscience, engineering, and machine learning to enable early detection and continuous monitoring outside clinical settings. Launching soon, Numen targets a future where cancer outcomes are dramatically improved through accessible, data-driven screening.

San Francisco, United States · HQ
Founded 2021171K+ followers
Updated 4 days ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Cancer mortality remains high largely because detection often occurs at advanced stages, and traditional diagnostic methods require clinic visits that are inconvenient, costly, and infrequent. Limited access to regular screening and the lack of continuous health data collection delay early intervention, which is critical for improving survival outcomes.

Solution

Numen is building infrastructure that enables rapid at-home diagnostics and streamlined high-volume health data collection, making it possible to detect cancer earlier and monitor health trends continuously. The platform integrates bioscience, engineering, and machine learning to process biological samples and health data efficiently, delivering actionable insights without requiring patients to visit a clinic. By simplifying the diagnostic workflow and scaling data collection, Numen aims to support proactive, data-driven healthcare that can reduce cancer mortality over time.

Target Audience

Primary customers are healthcare providers, diagnostic companies, and public health organizations seeking scalable, at-home screening solutions for early cancer detection and population-level health monitoring.

Features

  • Rapid at-home diagnostic tests designed for user-friendly self-administration
  • High-volume health data collection infrastructure that aggregates and processes large datasets
  • Machine learning algorithms applied to biological and health data for pattern detection and risk assessment
  • Integration of bioscience and engineering expertise to create end-to-end diagnostic solutions
  • Scalable platform architecture intended for broad population-level screening programs
This profile is AI-generated and may contain inaccuracies.